Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity

被引:19
作者
Ells, A. L. [1 ,2 ]
Gole, G. A. [3 ]
Hildebrand, P. Lloyd [4 ]
Ingram, A. [1 ]
Wilson, C. M. [5 ,6 ]
Williams, R. Geoff [2 ,7 ]
机构
[1] Ells Retina Ctr, Calgary, AB T2T 5R6, Canada
[2] Univ Calgary, Fac Med, Dept Ophthalmol, Calgary, AB, Canada
[3] Univ Queensland, Discipline Paediat & Child Hlth, Royal Childrens Hosp, Brisbane, Qld, Australia
[4] Univ Oklahoma, Dept Ophthalmol, Oklahoma City, OK USA
[5] City Univ London, Dept Optometry & Visual Sci, London, England
[6] St Marys Hosp, Dept Ophthalmol, London, England
[7] Calgary Retina Consultants, Calgary, AB, Canada
关键词
laser photocoagulation; neovascular ridge; posterior laser treatment; retinopathy of prematurity; ENDOTHELIAL GROWTH-FACTOR; THRESHOLD RETINOPATHY; RETROLENTAL FIBROPLASIA; AVASCULAR RETINA; PHOTOCOAGULATION; DETACHMENT; MODEL;
D O I
10.1038/eye.2012.302
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Current methods of treating the avascular retina with laser photocoagulation for severe retinopathy of prematurity (ROP) are not completely effective in the reduction of visual morbidity. We report a case series in which additional laser treatment, called 'posterior laser', was delivered posterior to the neovascular ridge, for eyes with severe stage 3 ROP in zone II with avascular retina posterior to the ridge. Design Retrospective chart review. Participants Infants who underwent laser treatment, posterior to the neovascular ridge for severe ROP at the Alberta Children's Hospital, between January 2005 and October 2008. Methods Charts were reviewed for 18 eyes of 11 patients and collected information included demographic data, clinical examination results, and digital retinal images. Main Outcome Measures Structural and functional outcomes of treatment. Results Four (22%) of 18 eyes received 'posterior laser' as primary treatment and the remainder of eyes (78%) received 'posterior laser' following previous laser photocoagulation anterior to the neovascular ridge. Mean birthweight was 688 g (552-930) and mean gestational age was 24 weeks (23-28). There were no complications because of the posterior laser treatment. In all, 16 of 18 eyes experienced rapid regression of the ridge and subsequent decrease in vascular dilation and tortuosity within 1 week. Two eyes required vitrectomy for 4A retinal detachment; however, no eyes developed stage 4B ROP. Conclusion Posterior to the ridge laser in the setting of the morphological criteria described had no increased safety concerns and resulted in rapid regression of ROP with good outcomes. Eye (2013) 27, 525-530; doi:10.1038/eye.2012.302; published online 18 January 2013
引用
收藏
页码:525 / 530
页数:6
相关论文
共 27 条
  • [1] Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity
    Axer-Siegel, R
    Snir, M
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (01): : 126 - 127
  • [2] Diode laser treatment of posterior retinopathy of prematurity
    Axer-Siegel, R
    Snir, M
    Cotlear, D
    Maayan, A
    Frilling, R
    Rosenbaltt, I
    Weinberger, D
    Kremer, I
    Sirota, L
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (12) : 1383 - 1386
  • [3] Diode laser treatment of retinopathy of prematurity - Anatomical and refractive outcomes
    Axer-Siegel, Ruth
    Maharshak, Idit
    Snir, Moshe
    Friling, Ronit
    Ehrlich, Rita
    Sherf, Ilana
    Shalev, Benjamin
    Sirota, Lea
    Weinberger, Dov
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (06): : 839 - 846
  • [4] Desmin ensheathment ratio as an indicator of vessel stability - Evidence in normal development and in retinopathy of prematurity
    Chan-Ling, T
    Page, MP
    Gardiner, T
    Baxter, L
    Rosinova, E
    Hughes, S
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) : 1301 - 1313
  • [5] In Vivo Characterization of Astrocyte Precursor Cells (APCs) and Astrocytes in Developing Rat Retinae: Differentiation, Proliferation, and Apoptosis
    Chan-Ling, Tailoi
    Chu, Yi
    Baxter, Louise
    Weible, Michael, II
    Hughes, Suzanne
    [J]. GLIA, 2009, 57 (01) : 39 - 53
  • [6] Are we there yet? Bevacizumab therapy for retinopathy of prematurity
    Darlow, Brian A.
    Ells, Anna L.
    Gilbert, Clare E.
    Gole, Glen A.
    Quinn, Graham E.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2013, 98 (02): : F170 - F174
  • [7] Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110
  • [8] FRAMBACH DA, 1982, INVEST OPHTH VIS SCI, V22, P292
  • [9] Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs
    Gilbert, C
    Fielder, A
    Gordillo, L
    Quinn, G
    Semiglia, R
    Visintin, P
    Zin, A
    [J]. PEDIATRICS, 2005, 115 (05) : E518 - E525
  • [10] The international classification of retinopathy of prematurity revisited
    Gole, GA
    Ells, AL
    Katz, X
    Holmstrom, G
    Fielder, AR
    Capone, A
    Flynn, JT
    Good, WG
    Holmes, JM
    McNamara, JA
    Palmer, EA
    Quinn, GE
    Shapiro, MJ
    Trese, MGJ
    Wallace, DK
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (07) : 991 - 999